Stay updated on PROMO: Pembrolizumab in Osteosarcoma Clinical Trial
Sign up to get notified when there's something new on the PROMO: Pembrolizumab in Osteosarcoma Clinical Trial page.

Latest updates to the PROMO: Pembrolizumab in Osteosarcoma Clinical Trial page
- Check5 days agoChange DetectedThe page revision tag changed from v3.6.5 to v3.6.6, indicating a new version of the page. This update does not alter the study content or related information presented on the page.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe page revision label in the footer changed from v3.6.4 to v3.6.5, indicating an updated build of the ClinicalTrials.gov page.SummaryDifference0.1%

- Check40 days agoChange DetectedThe page revision tag was updated from v3.6.3 to v3.6.4, indicating a small maintenance update to the page's versioning rather than substantive changes to the study details.SummaryDifference0.1%

- Check61 days agoChange DetectedRevision label on the page was updated from v3.6.2 to v3.6.3, indicating a new site release. This appears to be a maintenance update rather than a change to study information.SummaryDifference0.1%

- Check68 days agoChange DetectedThe page now displays Revision: v3.6.2, replacing Revision: v3.6.0. This reflects a new release version of the site interface without altering the study information or user-facing content.SummaryDifference0.1%

- Check83 days agoChange DetectedRecruitment status was updated to indicate no longer looking for participants. New help/navigation items (How to Read a Study Record, Common Questions, How to Join a Study) were added, a label formatting change for Intervention/Treatment was made, and the site revision tag was updated to v3.6.0.SummaryDifference0.6%

Stay in the know with updates to PROMO: Pembrolizumab in Osteosarcoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PROMO: Pembrolizumab in Osteosarcoma Clinical Trial page.